Eliezer Van Allen, M.D.
Eliezer Van Allen is an institute member at the Broad Institute of MIT and Harvard, an associate professor of medicine at Harvard Medical School, and chief of the Division of Population Sciences at the Dana-Farber Cancer Institute. His areas of focus are computational cancer genomics, the application of new molecular technologies to advance precision cancer medicine, and studying resistance to cancer therapeutics using biologically guided artificial intelligence. Van Allen’s current research includes integrative studies of genitourinary (prostate, bladder, kidney, and testicular) cancers to determine the appropriate treatment for individual patients.
Van Allen earned a B.S. from the Symbolic Systems Program at Stanford University and his M.D. from the David Geffen School of Medicine at UCLA. He completed his residency in internal medicine at the University of California, San Francisco, and served as a fellow in medical oncology at Dana-Farber.